Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells

BACKGROUND: Airway inflammation is a key feature of chronic obstructive pulmonary disease (COPD) and inhaled corticosteroids (ICS) remain the main treatment for airway inflammation. Studies have noted the increased efficacy of ICS and long-acting beta 2 agonist (LABA) combination therapy in controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Nan, Singhera, Gurpreet K., Yan, Yi Xuan, Pieper, Michael P., Leung, Janice M., Sin, Don D., Dorscheid, Delbert R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901009/
https://www.ncbi.nlm.nih.gov/pubmed/33622325
http://dx.doi.org/10.1186/s12931-021-01659-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901009/
https://www.ncbi.nlm.nih.gov/pubmed/33622325
http://dx.doi.org/10.1186/s12931-021-01659-2

Ejemplares similares